FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2760861695> ?p ?o ?g. }

• W2760861695 endingPage "88964" @default.
• W2760861695 startingPage "88951" @default.
• W2760861695 abstract "// Pei-Wen Wang 1, * , Yu-Ching Hung 2, 3, * , Tung-Ho Wu 4, * , Mu-Hong Chen 5, 6 , Chau-Ting Yeh 7 and Tai-Long Pan 3, 7, 8, 9 1 Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan 2 Department of Chinese Internal Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan 3 School of Traditional Chinese Medicine, Chang Gung University, Taoyuan, Taiwan 4 Division of Cardiovascular Surgery, Veterans General Hospital, Kaohsiung, Taiwan 5 Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan 6 Department of Psychiatry, College of Medicine, National Yang-Ming University, Taipei, Taiwan 7 Liver Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan 8 Research Center for Chinese Herbal Medicine and Research Center for Food and Cosmetic Safety, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan, Taiwan 9 Chinese Herbal Medicine Research Team, Healthy Aging Research Center, Chang Gung University, Taoyuan, Taiwan * These authors have contributed equally to this work Correspondence to: Tai-Long Pan, email: pan@mail.cgu.edu.tw Chau-Ting Yeh, email: chautingy@gmail.com Keywords: hepatic fibrosis, proteome, dimethylnitrosamine, ApoA4, network analysis Received: July 26, 2017      Accepted: August 28, 2017      Published: October 06, 2017 ABSTRACT Hepatic fibrosis may ultimately result in organ failure and death, a reality compounded by the fact that most drugs for liver fibrosis appear to be effective only if given as a prophylactic or early treatment. In a dimethylnitrosamine-induced liver fibrotic model, aspartate aminotransferase/alanine aminotransferase levels could not precisely distinguish the differences between the initial stage of liver fibrosis and normal control, whereas histological examination indicated that dimethylnitrosamine treatment for two weeks has resulted in hepatic fibrogenesis. Comprehensive proteomics identified 12 proteins mainly associated with the interleukin 6-stimulated inflammatory pathway. Coordinately, cytokine profiles showed that dimethylnitrosamine administration would stimulate various signaling pathways leading to liver fibrosis. Of note, apolipoprotein A4 in serum samples obtained from patients in the early stage of liver fibrosis were significantly increased compared to the healthy controls ( p <0.001) while the area under curve was 0.966. Moreover, increased apolipoprotein A4 significantly enhanced transforming growth factor beta 1-induced alpha smooth muscle actin expression. In this regard, overexpression of apolipoprotein A4 in early stage of liver fibrosis might magnify and imply the progression of hepatic fibrosis. These findings suggest that apolipoprotein A4 upregulation may correlate with hepatic fibrosis staging and that apolipoprotein A4 together with current biomarker can increase the sensitivity and specificity for the early detection of liver fibrosis in a high-throughput manner." @default.
• W2760861695 created "2017-10-20" @default.
• W2760861695 creator A5006893740 @default.
• W2760861695 creator A5016720326 @default.
• W2760861695 creator A5022040282 @default.
• W2760861695 creator A5034399195 @default.
• W2760861695 creator A5054020049 @default.
• W2760861695 creator A5066620141 @default.
• W2760861695 date "2017-10-06" @default.
• W2760861695 modified "2023-10-18" @default.
• W2760861695 title "Proteome-based identification of apolipoprotein A-IV as an early diagnostic biomarker in liver fibrosis" @default.
• W2760861695 cites W1016707613 @default.
• W2760861695 cites W1496588321 @default.
• W2760861695 cites W1506856062 @default.
• W2760861695 cites W1844303090 @default.
• W2760861695 cites W1964770927 @default.
• W2760861695 cites W1968789866 @default.
• W2760861695 cites W1978814081 @default.
• W2760861695 cites W1989972908 @default.
• W2760861695 cites W1995182877 @default.
• W2760861695 cites W1995428194 @default.
• W2760861695 cites W2000369852 @default.
• W2760861695 cites W202107448 @default.
• W2760861695 cites W2033591950 @default.
• W2760861695 cites W2038160689 @default.
• W2760861695 cites W2040995150 @default.
• W2760861695 cites W2045686436 @default.
• W2760861695 cites W2055447242 @default.
• W2760861695 cites W2057545989 @default.
• W2760861695 cites W2067585219 @default.
• W2760861695 cites W2067645178 @default.
• W2760861695 cites W2068149517 @default.
• W2760861695 cites W2072861622 @default.
• W2760861695 cites W2096430299 @default.
• W2760861695 cites W2108485031 @default.
• W2760861695 cites W2121387541 @default.
• W2760861695 cites W2124190432 @default.
• W2760861695 cites W2152206943 @default.
• W2760861695 cites W2166723565 @default.
• W2760861695 cites W2171530143 @default.
• W2760861695 cites W2173754051 @default.
• W2760861695 cites W2305677244 @default.
• W2760861695 cites W2328176404 @default.
• W2760861695 cites W2510546371 @default.
• W2760861695 cites W2563609186 @default.
• W2760861695 cites W4210986718 @default.
• W2760861695 doi "https://doi.org/10.18632/oncotarget.21627" @default.
• W2760861695 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5687660" @default.
• W2760861695 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29179490" @default.
• W2760861695 hasPublicationYear "2017" @default.
• W2760861695 type Work @default.
• W2760861695 sameAs 2760861695 @default.
• W2760861695 citedByCount "14" @default.
• W2760861695 countsByYear W27608616952018 @default.
• W2760861695 countsByYear W27608616952019 @default.
• W2760861695 countsByYear W27608616952020 @default.
• W2760861695 countsByYear W27608616952021 @default.
• W2760861695 countsByYear W27608616952022 @default.
• W2760861695 crossrefType "journal-article" @default.
• W2760861695 hasAuthorship W2760861695A5006893740 @default.
• W2760861695 hasAuthorship W2760861695A5016720326 @default.
• W2760861695 hasAuthorship W2760861695A5022040282 @default.
• W2760861695 hasAuthorship W2760861695A5034399195 @default.
• W2760861695 hasAuthorship W2760861695A5054020049 @default.
• W2760861695 hasAuthorship W2760861695A5066620141 @default.
• W2760861695 hasBestOaLocation W27608616951 @default.
• W2760861695 hasConcept C126322002 @default.
• W2760861695 hasConcept C142724271 @default.
• W2760861695 hasConcept C17744445 @default.
• W2760861695 hasConcept C188947578 @default.
• W2760861695 hasConcept C191935318 @default.
• W2760861695 hasConcept C199539241 @default.
• W2760861695 hasConcept C204787440 @default.
• W2760861695 hasConcept C2992019943 @default.
• W2760861695 hasConcept C44519122 @default.
• W2760861695 hasConcept C512399662 @default.
• W2760861695 hasConcept C71924100 @default.
• W2760861695 hasConceptScore W2760861695C126322002 @default.
• W2760861695 hasConceptScore W2760861695C142724271 @default.
• W2760861695 hasConceptScore W2760861695C17744445 @default.
• W2760861695 hasConceptScore W2760861695C188947578 @default.
• W2760861695 hasConceptScore W2760861695C191935318 @default.
• W2760861695 hasConceptScore W2760861695C199539241 @default.
• W2760861695 hasConceptScore W2760861695C204787440 @default.
• W2760861695 hasConceptScore W2760861695C2992019943 @default.
• W2760861695 hasConceptScore W2760861695C44519122 @default.
• W2760861695 hasConceptScore W2760861695C512399662 @default.
• W2760861695 hasConceptScore W2760861695C71924100 @default.
• W2760861695 hasIssue "51" @default.
• W2760861695 hasLocation W27608616951 @default.
• W2760861695 hasLocation W27608616952 @default.
• W2760861695 hasLocation W27608616953 @default.
• W2760861695 hasLocation W27608616954 @default.
• W2760861695 hasOpenAccess W2760861695 @default.
• W2760861695 hasPrimaryLocation W27608616951 @default.
• W2760861695 hasRelatedWork W2062044379 @default.
• W2760861695 hasRelatedWork W2348691329 @default.
• W2760861695 hasRelatedWork W2359315784 @default.

• next